BCBA/NTRAD (BCBA/NTRAD)

Buenos Aires Stock Exchange: BCBA/NTRAD · USD

$8.98

+0.39 (+4.5%)· Recorded snapshot

Market cap	95.4T
Revenue (ttm)	4T
Net income (ttm)	-285B
EPS (ttm)	-$41.5
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4T
Net income (ttm): -285B
EPS (ttm): -$41.5
Market cap: 95.4T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-12.5

P25 n/aP50 n/aP75 n/a

ROIC-10.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/NTRAD indicators

Market & fundamental data

Available fields

164

Groups with data

Currency

USD

Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-06
Employees	6,140
Employees change	1,706
Employees growth	38.48%
Enterprise value	$94.1T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	December
Founded	2003
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	AR0776810878
Last refreshed	2026-10-29
Market cap	$95.4T
Next earnings date	2026-11-06
Price	$8.98
Price currency	USD
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	bcba/NTRAD
Website	https://www.natera.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-0.31%
EV/FCF	719.72x
EV/Sales	21.56x
FCF / EV yield	0.14%
FCF yield	0.14%
P/B ratio	33.75x
P/FCF ratio	730.24x
P/OCF ratio	269.38x
P/S ratio	22.71x
Price / tangible book value	46.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-10.54%
EBITDA margin	-8.29%
FCF margin	2.99%
Gross margin	65.23%
Operating margin	-10.54%
Pretax margin	-9.33%
Profit margin	-7.11%
Profit per employee	$-46.4M
Revenue per employee	$653.4M
ROA	-8.08%
ROA (5Y)	-18.17%
ROCE	-13.55%
ROE	-12.54%
ROE (5Y)	-51.25%
ROIC	-10.18%
SBC / revenue	14.09%
Tax / revenue	-2.23%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	3
FCF growth	-19.47%
Gross profit growth	43.01%
Gross profit growth (Q)	39.98%
Gross profit growth 3Y	64.6%
Gross profit growth 5Y	47.82%
Net income growth quarters	1
Net income growth years	0
OCF growth	22.25%
OCF growth (Q)	45.83%
OCF growth (QoQ)	36.4%
Revenue growth	37.82%
Revenue growth (Q)	37.72%
Revenue growth (QoQ)	8.05%
Revenue growth 10Y	29.03%
Revenue growth 3Y	42.73%
Revenue growth 5Y	39.92%
Revenue growth quarters	37
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-213.4B
Depreciation and amortization	$93.7B
EBIT	$-422.6B
EBITDA	$-332.5B
EPS	$-41.50
Financing cash flow	$74.5B
Free cash flow	$124.7B
Free cash flow minus SBC	$-440.3B
Gross profit	$2.6T
Income taxes	$-89.4B
Investing cash flow	$-277.1B
Net cash flow	$135.5B
Net income	$-285B
Operating cash flow minus SBC	$-226.9B
Operating income	$-422.6B
Revenue	$4T
Stock-based compensation	$565.1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	19.48
Book value per share	$18,790.57
Debt / equity	0.13
Debt / FCF	2.83
Goodwill	$217.5B
Interest coverage	-74.72
Long-term assets	$1.4T
Long-term liabilities	$385.6B
Net cash (debt)	$1.3T
Net cash / market cap	1.39%
Net cash growth	4.04%
Net debt / equity	-0.47
Net debt / FCF	-10.13
Piotroski F-Score	4
Property, plant and equipment	$689.5B
Shareholders' equity	$2.7T
Tangible book value	$2T
Tangible book value per share	$13,619.12
Total assets	$3.9T
Total cash	$1.6T
Total debt	$353.3B
Total liabilities	$1.2T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.23
Current assets	$2.6T
Current liabilities	$852.9B
Current ratio	3
Inventory turnover	13.98
Net working capital	$162.5B
Quick ratio	2.74
Working capital	$1.6T
Working capital turnover	3,726.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-6.45%
Shareholder yield	-6.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	4.54%
1M price change	9.57%
1M total return	9.57%
1W price change	0.82%
1W total return	0.82%
20-day SMA	$7.89
52-week high	$8.98
52-week high date	2026-10-05
52-week low	$6.67
52-week low date	2026-09-03
All-time high	$8.98
All-time high date	2026-10-28
All-time low	$6.67
All-time low date	2026-09-03
Average true range (ATR)	$0.22
Average volume	196.8
Change from 52-week high	0%
Change from 52-week low	34.63%
Change from all-time high	0%
Change from all-time low	28.79%
Change from open	0%
Day's gap	4.54%
High price	$8.98
Low price	$8.98
Monthly RSI	0
Open price	$8.98
Previous close	$8.59
Price vs 20-day SMA	8.93%
Relative volume	0.07
RSI	69.11
Sharpe ratio	4.93
Sortino ratio	9.11
Volume	0
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	140.1M
Shares change (QoQ)	1.26%
Shares change (YoY)	6.45%
Shares held by insiders	2.74%
Shares held by institutions	96.89%
Short ratio	3.9 days

Deeper analysis on BCBA/NTRAD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/NTRAD report

Is a complete BCBA/NTRAD research report available?

No complete published report is available for bcba/NTRAD (BCBA/NTRAD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/NTRAD (BCBA/NTRAD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/NTRAD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/NTRAD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/NTRAD

Frequently asked questions